FREMANEZUMAB
fremanezumab 225 mg/1.5 mL injection, 1.5 mL pen device
FREMANEZUMAB (13129B)
13129B
Body System:
Manner of administration:Injection
Restriction 14563
Indication: Treatment-resistant migraine
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $560.72 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||